World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
162
Citations
148067
World Ranking
694
National Ranking
11

Overview

Lars Køber is affiliated with Copenhagen University Hospital in Denmark. Their primary area of research is within Medicine, encompassing 1,709 publications. The main subfields of their study include Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Epidemiology, Surgery, and Radiology, Nuclear Medicine and Imaging.

The scientist's research focuses on several key topics, including Cardiovascular Function and Risk Factors, Heart Failure Treatment and Management, Diabetes Treatment and Management, Cardiac Imaging and Diagnostics, Cardiac Valve Diseases and Treatments, Acute Myocardial Infarction Research, and Infective Endocarditis Diagnosis and Management.

Lars Køber has contributed to research published in several prominent journals. The most frequent publication venues are:

  • European Heart Journal
  • European Journal of Heart Failure
  • Circulation
  • Journal of the American College of Cardiology
  • American Heart Journal

Their recent notable papers include:

  • 2023 ESC Guidelines for the management of acute coronary syndromes, 2023, European Heart Journal
  • 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, 2023, European Heart Journal
  • 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS), 2024, European Heart Journal
  • 2024 ESC Guidelines for the management of chronic coronary syndromes, 2024, European Heart Journal
  • 2023 ESC Guidelines for the management of endocarditis, 2023, European Heart Journal

They have collaborated frequently with co-authors including Emil Loldrup Fosbøl, Christian Torp-Pedersen, Gunnar Gislason, John J.V. McMurray, and Scott D. Solomon.

Best Publications

  • ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

    Stamatis Adamopoulos;Stefan D. Anker;Volkmar Falk;Lars Køber

  • ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

    John J.V. McMurray;Stamatis Adamopoulos;Stefan D. Anker;Angelo Auricchio

  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber

  • Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

    Marc A. Pfeffer;John J.V. McMurray;Eric J. Velazquez;Jean-Lucien Rouleau

  • Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest

    Niklas Nielsen;Jørn Wetterslev;Tobias Cronberg;David Erlinge

  • Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.

    Nagesh S Anavekar;John J V McMurray;Eric J Velazquez;Scott D Solomon

  • A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.

    Køber L;Torp-Pedersen C;Carlsen Je;Bagger H

  • Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

    Marc A. Pfeffer;Brian L. Claggett;Rafael Diaz;Kenneth Dickstein

  • Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients

    Marcus D. Flather;Salim Yusuf;Lars Køber;Marc Pfeffer

  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino

  • Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

    Lars Køber;Jens J. Thune;Jens J. Thune;Jens C. Nielsen;Jens C. Nielsen;Jens Haarbo;Jens Haarbo

  • Targeted Anticytokine Therapy in Patients with Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)

    Douglas L. Mann;John J.V. McMurray;Milton Packer;Karl Swedberg

  • Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.

    C Torp-Pedersen;M Møller;P E Bloch-Thomsen;L Køber

  • Association of National Initiatives to Improve Cardiac Arrest Management With Rates of Bystander Intervention and Patient Survival After Out-of-Hospital Cardiac Arrest

    Mads Wissenberg;Freddy K. Lippert;Fredrik Folke;Peter Weeke

  • Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

    Søren L Kristensen;Søren L Kristensen;Rasmus Rørth;Rasmus Rørth;Pardeep S Jhund;Kieran F Docherty

  • Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies.

    Stuart J. Pocock;Cono A. Ariti;John J. V. McMurray;Aldo Pietro Maggioni

  • Increased Mortality after Dronedarone Therapy for Severe Heart Failure

    Lars Køber;Christian Torp-Pedersen;John J.V. McMurray;Ole Gøtzsche

  • Aliskiren, ALTITUDE, and the implications for ATMOSPHERE

    John J.V. McMurray;William T. Abraham;Kenneth Dickstein;Lars Køber

  • Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease

    Jonas Bjerring Olesen;Gregory Y H Lip;Anne-Lise Kamper;Kristine Hommel

  • Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.

    Morten L. Hansen;Rikke Sørensen;Mette T. Clausen;Marie Louise Fog-Petersen

Frequent Co-Authors

Christian Torp-Pedersen
Christian Torp-Pedersen Aalborg University
Gunnar H. Gislason
Gunnar H. Gislason Copenhagen University Hospital
John J.V. McMurray
John J.V. McMurray University of Glasgow
Scott D. Solomon
Scott D. Solomon Brigham and Women's Hospital
Christian Hassager
Christian Hassager University of Copenhagen
Marc A. Pfeffer
Marc A. Pfeffer Harvard Medical School
Pardeep S. Jhund
Pardeep S. Jhund University of Glasgow
Jesper Hastrup Svendsen
Jesper Hastrup Svendsen Copenhagen University Hospital
Karl Swedberg
Karl Swedberg University of Gothenburg
Aldo P. Maggioni
Aldo P. Maggioni Heart Care Foundation, ANMCO Research Center, Florence

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online healthcare programs can provide flexible and convenient pathways into the medical field, especially if you’re seeking alternatives to a traditional M.D. Online nursing degrees are a popular option. For those interested in advanced practice, a dnp program without clinical hours can help reduce in-person requirements, making it possible to balance work and study.

If you’re looking to enter the field quickly, accredited lpn programs can help you qualify as a Licensed Practical Nurse in a short period of time. For those passionate about mental health, the fastest pmhnp program can prepare you to become a Psychiatric Mental Health Nurse Practitioner, often in just two years.

Beyond clinical roles, management positions in healthcare are in high demand. Consider pursuing the cheapest online healthcare administration degree to develop leadership skills for hospital or clinic settings.

Each pathway offers unique benefits and entry requirements, and choosing the right option depends on your career goals, timeline, and interests.

Best Scientists Citing Lars Køber

Trending Scientists